50242-137Level 3
ACTEMRA (tocilizumab)
**Product type:** Human Prescription Drug
**Active ingredient:** TOCILIZUMAB
**Strength:** 400 mg/20mL
**Dosage form:** Injection, Solution, Concentrate
**Route:** Intravenous
**Labeler:** Genentech, Inc.
**Marketing category:** BLA (BLA125276)
**Pharmacologic class:** Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/50242-137Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.